▶ 調査レポート

糖尿病性足潰瘍治療のグローバル市場（2023年-2031年）：創傷治療ドレッシング、創傷治療機器、活性療法、抗生物質薬、その他
• 英文タイトル：Diabetic Foot Ulcers Treatment Market (Treatment Type: Wound Care Dressings, Wound Care Devices, Active Therapies, Antibiotic Medications, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

Transparency Market Researchが調査・発行した産業分析レポートです。糖尿病性足潰瘍治療のグローバル市場（2023年-2031年）：創傷治療ドレッシング、創傷治療機器、活性療法、抗生物質薬、その他 / Diabetic Foot Ulcers Treatment Market (Treatment Type: Wound Care Dressings, Wound Care Devices, Active Therapies, Antibiotic Medications, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031 / MRC2401A115資料のイメージです。• レポートコード：MRC2401A115
• 出版社/出版日：Transparency Market Research / 2023年11月
• レポート形態：英文、PDF、264ページ
• 納品方法：Eメール
• 産業分類：医療
• 販売価格（消費税別）
  Single User￥857,660 (USD5,795)▷ お問い合わせ
  Multi User￥1,301,660 (USD8,795)▷ お問い合わせ
  Corporate License￥1,745,660 (USD11,795)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
糖尿病性足潰瘍治療市場-レポート範囲
TMRの調査レポート「世界の糖尿病性足潰瘍治療市場」は、2023年から2031年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会を調査しています。2023年を基準年、2031年を予測年として、2017年から2031年までの世界の糖尿病性足潰瘍治療市場の収益を提供しています。また、2023年から2031年までの世界の糖尿病性足潰瘍治療市場の複合年間成長率（CAGR %）も掲載しています。

本レポートは広範な調査を経て作成されました。主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施しました。二次調査では、主要企業の製品資料、年次報告書、プレスリリース、関連文書などを参照し、糖尿病性足潰瘍治療市場を理解しました。

二次調査には、インターネットソース、政府機関の統計データ、ウェブサイト、業界団体なども含まれます。アナリストはトップダウンアプローチとボトムアップアプローチを組み合わせて、世界の糖尿病性足潰瘍治療市場の様々な属性を調査しました。

本レポートには、調査範囲に含まれる様々なセグメントの成長動向のスナップショットとともに、詳細なエグゼクティブサマリーが含まれています。さらに、本レポートは世界の糖尿病性足潰瘍治療市場における競争ダイナミクスの変化に光を投げかけています。これらは、既存の市場プレイヤーだけでなく、世界の糖尿病性足潰瘍治療市場への参入に関心のある企業にとっても貴重なツールとなります。

本レポートでは、世界の糖尿病性足潰瘍治療市場の競争状況について掘り下げています。世界の糖尿病性足潰瘍治療市場で事業を展開する主要プレイヤーを特定し、各プレイヤーを様々な属性でプロファイルしています。会社概要、財務状況、最近の動向、SWOTは、本レポートで紹介されている世界の糖尿病性足潰瘍治療市場におけるプレイヤーの属性です。

世界の糖尿病性足潰瘍治療市場レポートで回答された主な質問
- 予測期間中の全地域における糖尿病性足潰瘍治療の売上高/収益は？
- 世界の糖尿病性足潰瘍治療市場におけるビジネスチャンスは？
- 市場の主な促進要因、阻害要因、機会、脅威は？
- 予測期間中に最も速いCAGRで拡大する地域市場は？
- 2031年に世界で最も高い収益を上げると予測されるセグメントは？
- 予測期間中に最も高いCAGRで拡大すると予測されるセグメントは？
- 世界市場で事業を展開する各企業の市場ポジションは？

調査目的・調査アプローチ
世界の糖尿病性足潰瘍治療市場に関する包括的なレポートは、概要から始まり、調査範囲と目的が続きます。本レポートでは、本調査の目的、市場で事業を展開する主要ベンダーと流通業者、製品の承認に関する規制シナリオについて詳しく解説しています。

本レポートは、読みやすさを考慮し、各セクションを章ごとに分割したレイアウトになっています。本レポートは、グラフと表を適切に配置した網羅的なコレクションで構成されています。主要セグメントの実績値と予測値を図式化することで、読者に視覚的に訴えかけます。また、主要セグメントの過去と予測期間末の市場シェアの比較も可能です。

本レポートでは、世界の糖尿病性足潰瘍治療市場を製品、エンドユーザー、地域の観点から分析。各基準の主要セグメントを詳細に調査し、2031年末時点の各セグメントにおける市場シェアを掲載しています。このような貴重な洞察により、市場関係者は世界糖尿病性足潰瘍治療市場への投資について十分な情報に基づいたビジネス上の意思決定を行うことができます。

1.　序論
2.　仮定・調査方法
3.　エグゼクティブサマリー：世界の糖尿病性足潰瘍治療市場
4.　市場概要
5.　主要インサイト
6.　世界の糖尿病性足潰瘍治療市場分析：治療種類別
7.　世界の糖尿病性足潰瘍治療市場分析：潰瘍グレード別
8.　世界の糖尿病性足潰瘍治療市場分析：潰瘍種類別
9.　世界の糖尿病性足潰瘍治療市場分析：エンドユーザー別
10.　世界の糖尿病性足潰瘍治療市場分析：地域別
11.　北米の糖尿病性足潰瘍治療市場分析
12.　ヨーロッパの糖尿病性足潰瘍治療市場分析
13.　アジア太平洋の糖尿病性足潰瘍治療市場分析
14.　中南米の糖尿病性足潰瘍治療市場分析
15.　中東・アフリカの糖尿病性足潰瘍治療市場分析
16.　競合環境

レポート目次

1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Diabetic Foot Ulcers Treatment Market
4. Market Overview
    4.1. Overview
    4.2. Market Dynamics
        4.2.1. Drivers
        4.2.2. Restraints
        4.2.3. Opportunities
    4.3. Global Diabetic Foot Ulcers Treatment Market Value Analysis and Forecast, 2023-2031
5. Key Insights
    5.1. Epidemiology of Diabetic Ulcer (foot ulcer, corneal ulcer, skin ulcers, mouth ulcer, and others)
    5.2. Regulatory and Reimbursement Scenario
    5.3. Key Treatment of Diabetic Ulcer & Clinical Trials On Diabetic Foot Ulcers
    5.4. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)
6. Global Diabetic Foot Ulcers Treatment Market Analysis, by Treatment Type
    6.1. Introduction
    6.2. Global Diabetic Foot Ulcers Treatment Market Share Analysis, by Treatment Type
    6.3. Global Diabetic Foot Ulcers Treatment Market Attractiveness Analysis, by Treatment Type
    6.4. Global Diabetic Foot Ulcers Treatment Market Analysis, by Treatment Type
    6.5. Global Diabetic Foot Ulcers Treatment Market Forecast, by Treatment Type
        6.5.1. Wound Care Dressings
            6.5.1.1. Antimicrobial Dressings
            6.5.1.2. Foam Dressings
            6.5.1.3. Film Dressings
            6.5.1.4. Alginate Dressings
            6.5.1.5. Hydrogel Dressings
            6.5.1.6. Hydrocolloid Dressings
            6.5.1.7. Collagen Dressings
        6.5.2. Wound Care Devices
            6.5.2.1. Negative Pressure Wound Therapy
            6.5.2.2. Ultrasound Therapy
            6.5.2.3. HBOT and PEMF Therapy
        6.5.3. Active Therapies
            6.5.3.1. Skin Grafts & Substitutes
            6.5.3.2. Growth Factors
            6.5.3.3. Hemostatic Agents & Sealants
        6.5.4. Antibiotic Medications
        6.5.5. Others
7. Global Diabetic Foot Ulcers Treatment Market Analysis, by Grade of Ulcer
    7.1. Introduction
    7.2. Global Diabetic Foot Ulcers Treatment Market Share Analysis, by Grade of Ulcer
    7.3. Global Diabetic Foot Ulcers Treatment Market Attractiveness Analysis, by Grade of Ulcer
    7.4. Global Diabetic Foot Ulcers Treatment Market Analysis, by Grade of Ulcer
    7.5. Global Diabetic Foot Ulcers Treatment Market Forecast, by Grade of Ulcer
        7.5.1. Grade 1
        7.5.2. Grade 2
        7.5.3. Grade 3
        7.5.4. Grade 4
        7.5.5. Grade 5
8. Global Diabetic Foot Ulcers Treatment Market Analysis, by Ulcer Type
    8.1. Introduction
    8.2. Global Diabetic Foot Ulcers Treatment Market Share Analysis, by Ulcer Type
    8.3. Global Diabetic Foot Ulcers Treatment Market Attractiveness Analysis, by Ulcer Type
    8.4. Global Diabetic Foot Ulcers Treatment Market Analysis, by Ulcer Type
    8.5. Global Diabetic Foot Ulcers Treatment Market Forecast, by Ulcer Type
        8.5.1. Neuropathic Ulcers
        8.5.2. Ischemic Ulcers
        8.5.3. Neuroischemic Ulcers
9. Global Diabetic Foot Ulcers Treatment Market Analysis, by End-user
    9.1. Introduction
    9.2. Global Diabetic Foot Ulcers Treatment Market Share Analysis, by End-user
    9.3. Global Diabetic Foot Ulcers Treatment Market Attractiveness Analysis, by End-user
    9.4. Global Diabetic Foot Ulcers Treatment Market Analysis, by End-user
    9.5. Global Diabetic Foot Ulcers Treatment Market Forecast, by End-user
        9.5.1. Hospital Inpatient Settings
        9.5.2. Hospital Outpatient Settings
        9.5.3. Community Health Centers
        9.5.4. Home Healthcare
10. Global Diabetic Foot Ulcers Treatment Market Analysis, by Region
    10.1. Introduction
    10.2. Global Diabetic Foot Ulcers Treatment Market Share Analysis, by Region
    10.3. Global Diabetic Foot Ulcers Treatment Market Attractiveness Analysis, by Region
    10.4. Global Diabetic Foot Ulcers Treatment Market Forecast, by Region
        10.4.1. North America
        10.4.2. Europe
        10.4.3. Asia Pacific
        10.4.4. Latin America
        10.4.5. Middle East & Africa
11. North America Diabetic Foot Ulcers Treatment Market Analysis
    11.1. Key Insights: North America Diabetic Foot Ulcers Treatment Market
    11.2. North America Diabetic Foot Ulcers Treatment Market Overview
    11.3. North America Diabetic Foot Ulcers Treatment Market Forecast, by Country
        11.3.1. U.S.
        11.3.2. Canada
    11.4. North America Diabetic Foot Ulcers Treatment Market Share & Attractiveness Analysis, by Treatment Type
    11.5. North America Diabetic Foot Ulcers Treatment Market Forecast, by Treatment Type
        11.5.1. Wound Care Dressings
            11.5.1.1. Antimicrobial Dressings
            11.5.1.2. Foam Dressings
            11.5.1.3. Film Dressings
            11.5.1.4. Alginate Dressings
            11.5.1.5. Hydrogel Dressings
            11.5.1.6. Hydrocolloid Dressings
            11.5.1.7. Collagen Dressings
        11.5.2. Wound Care Devices
            11.5.2.1. Negative Pressure Wound Therapy
            11.5.2.2. Ultrasound Therapy
            11.5.2.3. HBOT and PEMF Therapy
        11.5.3. Active Therapies
            11.5.3.1. Skin Grafts & Substitutes
            11.5.3.2. Growth Factors
            11.5.3.3. Hemostatic Agents & Sealants
        11.5.4. Antibiotic Medications
        11.5.5. Others
    11.6. North America Diabetic Foot Ulcers Treatment Market Share & Attractiveness Analysis, by Grade of Ulcer
    11.7. North America Diabetic Foot Ulcers Treatment Market Forecast, by Grade of Ulcer
        11.7.1. Grade 1
        11.7.2. Grade 2
        11.7.3. Grade 3
        11.7.4. Grade 4
        11.7.5. Grade 5
    11.8. North America Diabetic Foot Ulcers Treatment Market Share & Attractiveness Analysis, by Ulcer Type
    11.9. North America Diabetic Foot Ulcers Treatment Market Forecast, by Ulcer Type
        11.9.1. Neuropathic Ulcers
        11.9.2. Ischemic Ulcers
        11.9.3. Neuroischemic Ulcers
    11.10. North America Diabetic Foot Ulcers Treatment Market Share & Attractiveness Analysis, by End-user
    11.11. North America Diabetic Foot Ulcers Treatment Market Forecast, by End-user
        11.11.1. Hospital Inpatient Settings
        11.11.2. Hospital Outpatient Settings
        11.11.3. Community Health Centers
        11.11.4. Home Healthcare
12. Europe Diabetic Foot Ulcers Treatment Market Analysis
    12.1. Key Insights: Europe Diabetic Foot Ulcers Treatment Market
    12.2. Europe Diabetic Foot Ulcers Treatment Market Overview
    12.3. Europe Diabetic Foot Ulcers Treatment Market Forecast, by Country/Sub-region
        12.3.1. Germany
        12.3.2. U.K.
        12.3.3. France
        12.3.4. Italy
        12.3.5. Spain
        12.3.6. Rest of Europe
    12.4. Europe Diabetic Foot Ulcers Treatment Market Share & Attractiveness Analysis, by Treatment Type
    12.5. Europe Diabetic Foot Ulcers Treatment Market Forecast, by Treatment Type
        12.5.1. Wound Care Dressings
            12.5.1.1. Antimicrobial Dressings
            12.5.1.2. Foam Dressings
            12.5.1.3. Film Dressings
            12.5.1.4. Alginate Dressings
            12.5.1.5. Hydrogel Dressings
            12.5.1.6. Hydrocolloid Dressings
            12.5.1.7. Collagen Dressings
        12.5.2. Wound Care Devices
            12.5.2.1. Negative Pressure Wound Therapy
            12.5.2.2. Ultrasound Therapy
            12.5.2.3. HBOT and PEMF Therapy
        12.5.3. Active Therapies
            12.5.3.1. Skin Grafts & Substitutes
            12.5.3.2. Growth Factors
            12.5.3.3. Hemostatic Agents & Sealants
        12.5.4. Antibiotic Medications
        12.5.5. Others
    12.6. Europe Diabetic Foot Ulcers Treatment Market Share & Attractiveness Analysis, by Grade of Ulcer
    12.7. Europe Diabetic Foot Ulcers Treatment Market Forecast, by Grade of Ulcer
        12.7.1. Grade 1
        12.7.2. Grade 2
        12.7.3. Grade 3
        12.7.4. Grade 4
        12.7.5. Grade 5
    12.8. Europe Diabetic Foot Ulcers Treatment Market Share & Attractiveness Analysis, by Ulcer Type
    12.9. Europe Diabetic Foot Ulcers Treatment Market Forecast, by Ulcer Type
        12.9.1. Neuropathic Ulcers
        12.9.2. Ischemic Ulcers
        12.9.3. Neuroischemic Ulcers
    12.10. Europe Diabetic Foot Ulcers Treatment Market Share & Attractiveness Analysis, by End-user
    12.11. Europe Diabetic Foot Ulcers Treatment Market Forecast, by End-user
        12.11.1. Hospital Inpatient Settings
        12.11.2. Hospital Outpatient Settings
        12.11.3. Community Health Centers
        12.11.4. Home Healthcare
13. Asia Pacific Diabetic Foot Ulcers Treatment Market Analysis
    13.1. Key Insights: Asia Pacific Diabetic Foot Ulcers Treatment Market
    13.2. Asia Pacific Diabetic Foot Ulcers Treatment Market Overview
    13.3. Asia Pacific Diabetic Foot Ulcers Treatment Market Forecast, by Country/Sub-region
        13.3.1. China
        13.3.2. Japan
        13.3.3. India
        13.3.4. Australia & New Zealand
        13.3.5. Rest of Asia Pacific
    13.4. Asia Pacific Diabetic Foot Ulcers Treatment Market Share & Attractiveness Analysis, by Treatment Type
    13.5. Asia Pacific Diabetic Foot Ulcers Treatment Market Forecast, by Treatment Type
        13.5.1. Wound Care Dressings
            13.5.1.1. Antimicrobial Dressings
            13.5.1.2. Foam Dressings
            13.5.1.3. Film Dressings
            13.5.1.4. Alginate Dressings
            13.5.1.5. Hydrogel Dressings
            13.5.1.6. Hydrocolloid Dressings
            13.5.1.7. Collagen Dressings
        13.5.2. Wound Care Devices
            13.5.2.1. Negative Pressure Wound Therapy
            13.5.2.2. Ultrasound Therapy
            13.5.2.3. HBOT and PEMF Therapy
        13.5.3. Active Therapies
            13.5.3.1. Skin Grafts & Substitutes
            13.5.3.2. Growth Factors
            13.5.3.3. Hemostatic Agents & Sealants
        13.5.4. Antibiotic Medications
        13.5.5. Others
    13.6. Asia Pacific Diabetic Foot Ulcers Treatment Market Share & Attractiveness Analysis, by Grade of Ulcer
    13.7. Asia Pacific Diabetic Foot Ulcers Treatment Market Forecast, by Grade of Ulcer
        13.7.1. Grade 1
        13.7.2. Grade 2
        13.7.3. Grade 3
        13.7.4. Grade 4
        13.7.5. Grade 5
    13.8. Asia Pacific Diabetic Foot Ulcers Treatment Market Share & Attractiveness Analysis, by Ulcer Type
    13.9. Asia Pacific Diabetic Foot Ulcers Treatment Market Forecast, by Ulcer Type
        13.9.1. Neuropathic Ulcers
        13.9.2. Ischemic Ulcers
        13.9.3. Neuroischemic Ulcers
    13.10. Asia Pacific Diabetic Foot Ulcers Treatment Market Share & Attractiveness Analysis, by End-user
    13.11. Asia Pacific Diabetic Foot Ulcers Treatment Market Forecast, by End-user
        13.11.1. Hospital Inpatient Settings
        13.11.2. Hospital Outpatient Settings
        13.11.3. Community Health Centers
        13.11.4. Home Healthcare
14. Latin America Diabetic Foot Ulcers Treatment Market Analysis
    14.1. Key Insights: Latin America Diabetic Foot Ulcers Treatment Market
    14.2. Latin America Diabetic Foot Ulcers Treatment Market Overview
    14.3. Latin America Diabetic Foot Ulcers Treatment Market Forecast, by Country/Sub-region
        14.3.1. Brazil
        14.3.2. Mexico
        14.3.3. Rest of Latin America
    14.4. Latin America Diabetic Foot Ulcers Treatment Market Share & Attractiveness Analysis, by Treatment Type
    14.5. Latin America Diabetic Foot Ulcers Treatment Market Forecast, by Treatment Type
        14.5.1. Wound Care Dressings
            14.5.1.1. Antimicrobial Dressings
            14.5.1.2. Foam Dressings
            14.5.1.3. Film Dressings
            14.5.1.4. Alginate Dressings
            14.5.1.5. Hydrogel Dressings
            14.5.1.6. Hydrocolloid Dressings
            14.5.1.7. Collagen Dressings
        14.5.2. Wound Care Devices
            14.5.2.1. Negative Pressure Wound Therapy
            14.5.2.2. Ultrasound Therapy
            14.5.2.3. HBOT and PEMF Therapy
        14.5.3. Active Therapies
            14.5.3.1. Skin Grafts & Substitutes
            14.5.3.2. Growth Factors
            14.5.3.3. Hemostatic Agents & Sealants
        14.5.4. Antibiotic Medications
        14.5.5. Others
    14.6. Latin America Diabetic Foot Ulcers Treatment Market Share & Attractiveness Analysis, by Grade of Ulcer
    14.7. Latin America Diabetic Foot Ulcers Treatment Market Forecast, by Grade of Ulcer
        14.7.1. Grade 1
        14.7.2. Grade 2
        14.7.3. Grade 3
        14.7.4. Grade 4
        14.7.5. Grade 5
    14.8. Latin America Diabetic Foot Ulcers Treatment Market Share & Attractiveness Analysis, by Ulcer Type
    14.9. Latin America Diabetic Foot Ulcers Treatment Market Forecast, by Ulcer Type
        14.9.1. Neuropathic Ulcers
        14.9.2. Ischemic Ulcers
        14.9.3. Neuroischemic Ulcers
    14.10. Latin America Diabetic Foot Ulcers Treatment Market Share & Attractiveness Analysis, by End-user
    14.11. Latin America Diabetic Foot Ulcers Treatment Market Forecast, by End-user
        14.11.1. Hospital Inpatient Settings
        14.11.2. Hospital Outpatient Settings
        14.11.3. Community Health Centers
        14.11.4. Home Healthcare
15. Middle East & Africa Diabetic Foot Ulcers Treatment Market Analysis
    15.1. Key Insights: Middle East & Africa Diabetic Foot Ulcers Treatment Market
    15.2. Middle East & Africa Diabetic Foot Ulcers Treatment Market Overview
    15.3. Middle East & Africa Diabetic Foot Ulcers Treatment Market Forecast, by Country/Sub-region
        15.3.1. GCC Countries
        15.3.2. South Africa
        15.3.3. Rest of Middle East & Africa
    15.4. Middle East & Africa Diabetic Foot Ulcers Treatment Market Share & Attractiveness Analysis, by Treatment Type
    15.5. Middle East & Africa Diabetic Foot Ulcers Treatment Market Forecast, by Treatment Type
        15.5.1. Wound Care Dressings
            15.5.1.1. Antimicrobial Dressings
            15.5.1.2. Foam Dressings
            15.5.1.3. Film Dressings
            15.5.1.4. Alginate Dressings
            15.5.1.5. Hydrogel Dressings
            15.5.1.6. Hydrocolloid Dressings
            15.5.1.7. Collagen Dressings
        15.5.2. Wound Care Devices
            15.5.2.1. Negative Pressure Wound Therapy
            15.5.2.2. Ultrasound Therapy
            15.5.2.3. HBOT and PEMF Therapy
        15.5.3. Active Therapies
            15.5.3.1. Skin Grafts & Substitutes
            15.5.3.2. Growth Factors
            15.5.3.3. Hemostatic Agents & Sealants
        15.5.4. Antibiotic Medications
        15.5.5. Others
    15.6. Middle East & Africa Diabetic Foot Ulcers Treatment Market Share & Attractiveness Analysis, by Grade of Ulcer
    15.7. Middle East & Africa Diabetic Foot Ulcers Treatment Market Forecast, by Grade of Ulcer
        15.7.1. Grade 1
        15.7.2. Grade 2
        15.7.3. Grade 3
        15.7.4. Grade 4
        15.7.5. Grade 5
    15.8. Middle East & Africa Diabetic Foot Ulcers Treatment Market Share & Attractiveness Analysis, by Ulcer Type
    15.9. Middle East & Africa Diabetic Foot Ulcers Treatment Market Forecast, by Ulcer Type
        15.9.1. Neuropathic Ulcers
        15.9.2. Ischemic Ulcers
        15.9.3. Neuroischemic Ulcers
    15.10. Middle East & Africa Diabetic Foot Ulcers Treatment Market Share & Attractiveness Analysis, by End-user
    15.11. Middle East & Africa Diabetic Foot Ulcers Treatment Market Forecast, by End-user
        15.11.1. Hospital Inpatient Settings
        15.11.2. Hospital Outpatient Settings
        15.11.3. Community Health Centers
        15.11.4. Home Healthcare
16. Competition Landscape
    16.1. Market Player – Competition Matrix (by tier and size of companies)
    16.2. Market Share Analysis, by Company (2022)
    16.3. Company Profiles
        16.3.1. Convatec, Inc.
            16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.1.2. Product Portfolio
            16.3.1.3. Financial Overview
            16.3.1.4. SWOT Analysis
            16.3.1.5. Strategic Overview
        16.3.2. Integra LifeSciences Corporation
            16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.2.2. Product Portfolio
            16.3.2.3. Financial Overview
            16.3.2.4. SWOT Analysis
            16.3.2.5. Strategic Overview
        16.3.3. 3M Health Care
            16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.3.2. Product Portfolio
            16.3.3.3. Financial Overview
            16.3.3.4. SWOT Analysis
            16.3.3.5. Strategic Overview
        16.3.4. Coloplast Corp.
            16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.4.2. Product Portfolio
            16.3.4.3. Financial Overview
            16.3.4.4. SWOT Analysis
            16.3.4.5. Strategic Overview
        16.3.5. Smith & Nephew Plc.
            16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.5.2. Product Portfolio
            16.3.5.3. Financial Overview
            16.3.5.4. SWOT Analysis
            16.3.5.5. Strategic Overview
        16.3.6. B. Braun Melsungen AG
            16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.6.2. Product Portfolio
            16.3.6.3. Financial Overview
            16.3.6.4. SWOT Analysis
            16.3.6.5. Strategic Overview
        16.3.7. Medline Industries, Inc.
            16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.7.2. Product Portfolio
            16.3.7.3. Financial Overview
            16.3.7.4. SWOT Analysis
            16.3.7.5. Strategic Overview
        16.3.8. Organogenesis, Inc.
            16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.8.2. Product Portfolio
            16.3.8.3. Financial Overview
            16.3.8.4. SWOT Analysis
            16.3.8.5. Strategic Overview
        16.3.9. Mölnlycke Health Care
            16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.9.2. Product Portfolio
            16.3.9.3. Financial Overview
            16.3.9.4. SWOT Analysis
            16.3.9.5. Strategic Overview
        16.3.10. BSN medical GmbH
            16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.10.2. Product Portfolio
            16.3.10.3. Financial Overview
            16.3.10.4. SWOT Analysis
            16.3.10.5. Strategic Overview
        16.3.11. Cardinal Health
            16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.11.2. Product Portfolio
            16.3.11.3. Financial Overview
            16.3.11.4. SWOT Analysis
            16.3.11.5. Strategic Overview
        16.3.12. Orpyx Medical Technologies Inc.
            16.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.12.2. Product Portfolio
            16.3.12.3. Financial Overview
            16.3.12.4. SWOT Analysis
            16.3.12.5. Strategic Overview
        16.3.13. Compedica Holdings, Ltd.
            16.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.13.2. Product Portfolio
            16.3.13.3. Financial Overview
            16.3.13.4. SWOT Analysis
            16.3.13.5. Strategic Overview
        16.3.14. Tissue Regenix
            16.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.14.2. Product Portfolio
            16.3.14.3. Financial Overview
            16.3.14.4. SWOT Analysis
            16.3.14.5. Strategic Overview

List of Tables

Table 01: Global Diabetic Foot Ulcers Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2023-2031

Table 02: Global Diabetic Foot Ulcers Treatment Market Value (US$ Mn) Forecast, by Wound Care Dressings, 2023-2031

Table 03: Global Diabetic Foot Ulcers Treatment Market Value (US$ Mn) Forecast, by Wound Care Devices, 2023-2031

Table 04: Global Diabetic Foot Ulcers Treatment Market Value (US$ Mn) Forecast, by Wound Care Devices, 2023-2031

Table 05: Global Diabetic Foot Ulcers Treatment Market Value (US$ Mn) Forecast, by Grade of Ulcer of Ulcer, 2023-2031

Table 06: Global Diabetic Foot Ulcers Treatment Market Value (US$ Mn) Forecast, by Ulcer Type, 2023-2031

Table 07: Global Diabetic Foot Ulcers Treatment Market Value (US$ Mn) Forecast, by End-user, 2023-2031

Table 08: Global Diabetic Foot Ulcers Treatment Market Value (US$ Mn) Forecast, by Region, 2023-2031

Table 09: North America Diabetic Foot Ulcers Treatment Market Value (US$ Mn) Forecast, by Country, 2023-2031

Table 10: North America Diabetic Foot Ulcers Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2023-2031

Table 11: North America Diabetic Foot Ulcers Treatment Market Value (US$ Mn) Forecast, by Grade of Ulcer of Ulcer, 2023-2031

Table 12: North America Diabetic Foot Ulcers Treatment Market Value (US$ Mn) Forecast, by Ulcer Type, 2023-2031

Table 13: North America Diabetic Foot Ulcers Treatment Market Value (US$ Mn) Forecast, by End-user, 2023-2031

Table 14: Europe Diabetic Foot Ulcers Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031

Table 15: Europe Diabetic Foot Ulcers Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2023-2031

Table 16: Europe Diabetic Foot Ulcers Treatment Market Value (US$ Mn) Forecast, by Grade of Ulcer of Ulcer, 2023-2031

Table 17: Europe Diabetic Foot Ulcers Treatment Market Value (US$ Mn) Forecast, by Ulcer Type, 2023-2031

Table 18: Europe Diabetic Foot Ulcers Treatment Market Value (US$ Mn) Forecast, by End-user, 2023-2031

Table 19: Asia Pacific Diabetic Foot Ulcers Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031

Table 20: Asia Pacific Diabetic Foot Ulcers Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2023-2031

Table 21: Asia Pacific Diabetic Foot Ulcers Treatment Market Value (US$ Mn) Forecast, by Grade of Ulcer of Ulcer, 2023-2031

Table 22: Asia Pacific Diabetic Foot Ulcers Treatment Market Value (US$ Mn) Forecast, by Ulcer Type, 2023-2031

Table 23: Asia Pacific Diabetic Foot Ulcers Treatment Market Value (US$ Mn) Forecast, by End-user, 2023-2031

Table 24: Latin America Diabetic Foot Ulcers Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031

Table 25: Latin America Diabetic Foot Ulcers Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2023-2031

Table 26: Latin America Diabetic Foot Ulcers Treatment Market Value (US$ Mn) Forecast, by Grade of Ulcer of Ulcer, 2023-2031

Table 27: Latin America Diabetic Foot Ulcers Treatment Market Value (US$ Mn) Forecast, by Ulcer Type, 2023-2031

Table 28: Latin America Diabetic Foot Ulcers Treatment Market Value (US$ Mn) Forecast, by End-user, 2023-2031

Table 29: Middle East & Africa Diabetic Foot Ulcers Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031

Table 30: Middle East & Africa Diabetic Foot Ulcers Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2023-2031

Table 31: Middle East & Africa Diabetic Foot Ulcers Treatment Market Value (US$ Mn) Forecast, by Grade of Ulcer of Ulcer, 2023-2031

Table 32: Middle East & Africa Diabetic Foot Ulcers Treatment Market Value (US$ Mn) Forecast, by Ulcer Type, 2023-2031

Table 33: Middle East & Africa Diabetic Foot Ulcers Treatment Market Value (US$ Mn) Forecast, by End-user, 2023-2031
以下、関連資料のご紹介